Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Imaging Analysis of Tissue Changes Occurring During Treatment With Antiangiogenic (Bevacizumab) in Patients With Recurrent Glioblastoma

NCT02841332 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT02841332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02841332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Imaging Analysis of Tissue Changes Occurring During Treatment With Antiangiogenic (Bevacizumab) in Patients With Recurrent Glioblastoma
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2013
Completion date
December 31, 2016
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma